ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,546Medicare Part D Prescriptions Filled, Including Refills

Rank: 417 out of 972

$419K Total Retail Price of All Prescriptions

Rank: 407 out of 972

396 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 396 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 7,205 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 520 508 1 2
AMLODIPINE BESYLATE 319 310 2 4
ATORVASTATIN CALCIUM 264 250 3 11
LISINOPRIL 258 255 4 1
CARVEDILOL 249 245 5 21
LEVOTHYROXINE SODIUM 212 210 6 3
FUROSEMIDE 204 197 7 7
OMEPRAZOLE 196 191 8 5
CRESTOR 190 169 9 33
HYDROCHLOROTHIAZIDE 162 162 10 10
HYDROCODONE-ACETAMINOPHEN 148 133 S3 11 6
ATENOLOL 123 110 12 18
WARFARIN SODIUM 117 113 13 12
CIPROFLOXACIN HCL 109 103 14 63
ISOSORBIDE MONONITRATE ER 97 97 15 43
ZOLPIDEM TARTRATE 96 92 16 23
POTASSIUM CHLORIDE 96 96 16 13
METFORMIN HCL 93 91 18 8
AMITRIPTYLINE HCL 91 82 R 19 58
CLOPIDOGREL 90 83 20 37
METOPROLOL SUCCINATE 84 81 21 16
LOSARTAN POTASSIUM 82 82 22 17
PANTOPRAZOLE SODIUM 75 75 23 41
ALLOPURINOL 74 74 24 28
TRAMADOL HCL 74 71 24 15
LOSARTAN-HYDROCHLOROTHIAZIDE 72 72 26 61
GABAPENTIN 71 70 27 14
GEMFIBROZIL 71 71 27 93
MELOXICAM 69 69 29 36
METHYLPREDNISOLONE 69 65 29 119
LIPITOR 68 68 31 90
CYCLOBENZAPRINE HCL 67 67 R 32 53
METOPROLOL TARTRATE 64 64 33 9
DILTIAZEM ER 63 51 34 129
FENOFIBRATE 62 55 35 66
LOVASTATIN 62 58 35 22
DONEPEZIL HCL 56 56 37 26
PRAVASTATIN SODIUM 54 54 38 20
ZETIA 53 53 39 79
TAMSULOSIN HCL 51 49 40 29
CEFDINIR 51 46 40 187
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.